SPRC
Scisparc Ltd
NASDAQ · Pharmaceuticals
$0.68
+0.07 (+11.75%)
Open$0.63
Previous Close$0.61
Day High$0.68
Day Low$0.61
52W High$17.24
52W Low$8.81
Volume—
Avg Volume76.5K
Market Cap2.98M
P/E Ratio—
EPS$-0.07
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.37M | 1.35M | 1.33M |
| Net Income | 393.8K | 424.2K | 446.9K |
| Profit Margin | 28.8% | 31.3% | 33.6% |
| EBITDA | 809.4K | 830.6K | 717.6K |
| Free Cash Flow | 304.8K | 355.4K | 299.5K |
| Rev Growth | -0.9% | -3.8% | +21.8% |
| Debt/Equity | 0.83 | 1.09 | 0.85 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |